Akcea Therapeutics Email Format
Biotechnology ResearchMassachusetts, United States51-200 Employees
Akcea Therapeutics is a mid-sized biotechnology firm based in Cambridge, Massachusetts, founded in early 2015. It functions as a wholly owned subsidiary of Ionis Pharmaceuticals. The company markets two medicines and, together with Ionis, advances a mature pipeline of novel therapies discovered by Ionis using its antisense platform. Akcea focuses on delivering medicines by understanding patient and physician needs, preparing the market, establishing market access, and distributing products globally. Its work sits within the biotechnology research field, anchored in Ionis’ antisense technology. As part of Ionis’ ecosystem, Akcea contributes to translating discoveries into clinically available therapies.